In the third quarter, Lee Financial Co initiated a stake in UnitedHealth Group by acquiring 3,390 shares valued at roughly $1.17 million, according to its latest 13F filing. Brighton Jones LLC followed suit in the fourth quarter, boosting its holdings by 176.2% to 44,249 shares (approximately $22.38 million). Revolve Wealth Partners increased its position by 137.1%, adding 2,324 shares to reach 4,019 shares (about $2.03 million). Meanwhile, CMT Capital Markets Trading entered with a new $340,000 stake in Q2, and Patriot Financial Group Insurance Agency expanded its holding by 42.5% to 5,312 shares (valued at $1.66 million). Overall, institutional investors and hedge funds own 87.86% of the company’s shares, reflecting continued confidence from large asset managers.

UnitedHealth Group reported fourth-quarter adjusted earnings per share of $2.11, narrowly surpassing consensus forecasts by $0.02. Revenue reached $113.22 billion, marking a 12.3% year-over-year increase, albeit falling short of the $113.38 billion analyst estimate. The company’s net margin stood at 2.69%, and return on equity was 14.79%. For fiscal 2026, UnitedHealth projected full-year adjusted EPS of $17.75, which trails the street’s average estimate of $29.54, signaling investor caution around near-term profitability growth.

UnitedHealth maintains a conservative leverage profile with a debt-to-equity ratio of 0.72 and liquidity ratios of 0.82 (quick) and 0.79 (current), underscoring solid short-term funding capacity. Market capitalization stands near $260 billion, and the shares trade at a trailing P/E multiple of 21.8 and a PEG ratio of 1.35, indicating that the stock’s valuation aligns with its projected growth trajectory. Across technical indicators, the 50-day and 200-day moving averages cluster around the low-to-mid 300s, suggesting a key trading range for market participants.

The board declared a quarterly dividend of $2.21 per share, translating to an annualized payout of $8.84 and a yield of approximately 3.1%. With a payout ratio of 67.0%, UnitedHealth balances returning cash to investors with reinvestment in its business. The dividend was paid to shareholders of record in early December, reinforcing the company’s commitment to consistent income distributions despite earnings and guidance headwinds.